-
Pace of Pharmaceutical Innovation Accelerates as Record Number of New Blockbuster Drugs Forecast to Hit the Market in 2018
prnasia
March 23, 2018
Twelve new game-changing drugs predicted to achieve annual sales of >$1 billion by 2022, to the benefit of millions of patients around the world
-
Top Trends Impacting Biopharma Innovation Strategy in 2018
biospace
January 25, 2018
The biopharma industry is perceived to be at a turning point, where companies have the opportunity to meaningfully adapt their innovation strategy and take advantage of major technological advances and new therapeutic modalities.
-
HIT-ZHONGAO Biological Engineering -- An Innovation Oriented Enterprise
PharmaSources.com
December 13, 2017
Our company is a modern, high-tech, innovation oriented enterprise,is a high - tech biotechnology industry system.
-
Innovation with a purpose at Agilent
europeanpharmaceuticalreview
July 12, 2017
David Edwards explains how Agilent spectroscopy systems combine core qualities of robustness and reliability with a spirit of innovation.
-
Innovation with a purpose at Agilent
europeanpharmaceuticalreview
July 12, 2017
David Edwards explains how Agilent spectroscopy systems combine core qualities of robustness and reliability with a spirit of innovation.
-
BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target
b3cnewswire
June 28, 2017
Attracted by the strong performance of BioGeneration Ventures (BGV), new investors joined BGV III including the European Investment Fund, whose contribution comes from InnovFin Equity Facility and the Dutch Venture Initiative II
-
Seven New Research Parks to be set up in India to boost innovation
biospectrumasia
June 07, 2017
The government will be setting up five new bio-clusters, 50 new bio-incubators, 150 technology transfer offices and 20 bio-connect offices in research institutes and universities across India in order to support start-ups in the biotechnology sector.
-
A strong EU IP framework guarantees future innovation for patients
europeanpharmaceuticalreview
May 26, 2017
Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for
-
Grünenthal Opens Innovation Hub in Boston
americanpharmaceuticalreview
May 11, 2017
Grünenthal announced it opened a new Innovation Hub in the Greater Boston area.
-
IP: the fuel for innovation
lilly
April 27, 2017
This article comes from Elise Melon, Director Intellectual Property Policy at the European Federation of Pharmaceutical Industries and Associations (EFPIA).